Mohd Arif
Active Director Director DIN 07980550
DIN 07980550 First appointment Dec 2017 Primary industry Jewelry & Fashion Accessories
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2017
Shareholding value •••• Premium profile

About Mohd Arif

Data last updated:

Mohd Arif is a Director at Fyzoon Pharma Private Limited (since 2017). The company operates in Jewelry & Fashion Accessories. Fyzoon Pharma Private Limited reported revenue of ₹1.26 Cr (FY 2025).

DIN 07980550
Primary Designation Director
Industry Jewelry & Fashion Accessories
First Appointment 06 Dec 2017
Oldest Company Age 8 yrs
Largest company Fyzoon Pharma Private Limited · ₹1.26 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Fyzoon Pharma Private Limited U33309DL2017PTC326845
Director06 Dec 20172017₹1.26 Cr (FY 2025)Active

Board colleagues of Mohd Arif

NameDINCompanyDesignation
Mohd Khalid07980584Fyzoon Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Fyzoon Pharma Private Limited
Premium access

Shareholding and investment profile for Mohd Arif

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohd Arif

Mohd Arif currently holds 1 directorship: Fyzoon Pharma Private Limited (Director, since 06 Dec 2017, revenue ₹1.26 Cr (FY 2025)).

Mohd Arif was first appointed on 06 Dec 2017 as Director at Fyzoon Pharma Private Limited.

The current boards of Mohd Arif's companies include Mohd Khalid (Fyzoon Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available